Strategic Growth in the Global Antibody Drug Conjugate Market

adicionou um novo artigo Health

2026-03-09 11:33:51 -

The Antibody Drug Conjugate Market is experiencing robust growth due to breakthroughs in bioconjugation technologies. These therapies combine the specificity of monoclonal antibodies with potent cytotoxins, offering a promising approach to treat cancers resistant to standard chemotherapy. Investments in ADC research have expanded clinical pipelines, with new compounds targeting diverse cancer...

0 Comentários 0 Compartilhamentos 189 Visualizações 0 Anterior